A medicine based on MDMA – the active ingredient in recreational drug ecstasy – is on the cusp of FDA approval as a treatment for post-traumatic stress disorder (PTSD), according to the ...
Users of MDMA, or 'ecstasy', are more likely to experience sleep apneas (pauses in breathing) and hypopneas (overly shallow or slow breathing) than are nonusers, a new study has found. The results ...
One of the biggest stories of last year was Lykos Therapeutics’ failure to get its MDMA candidate over the finish line for post-traumatic stress disorder (PTSD). But the biotech has reminded us ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback